Starting in the 2027 plan year, PEHP must include non-opioid alternatives in the state employee drug plan and apply no stricter coverage rules to them than to opioid drugs.
Starting with the 2027 plan year, PEHP must include at least one clinically appropriate non-opioid prescription drug as an alternative for each opioid drug, within the stated funding and additional-funding requirements.
Starting with the 2027 plan year, PEHP must not make people pay more or meet stricter review requirements for a covered non-opioid drug than for a covered opioid drug.
PEHP must include at least one clinically appropriate non-opioid prescription drug as an alternative for each opioid prescription drug. This applies to the state employee health plan administered by PEHP. PEHP must carry out the resolution within an appropriation of $150,000 and request an additional appropriation if compliance costs more. The direction begins with the 2027 plan year.
PEHP must not place stricter cost-sharing or review requirements on a covered non-opioid prescription drug than on a covered opioid prescription drug. This applies to covered prescription drugs in the state employee health plan. The comparison applies to drugs covered by the PEHP plan. The direction begins with the 2027 plan year.
No hearings or votes scheduled.